Truvada Tablet, Film Coated
Product Images NDC 61958-0705
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Truvada (NDC 61958-0705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gilead Sciences, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Truvada 02)
Principal Display Panel (30 Tablet Bottle Label)
Truvada is a medication available in tablet form containing 200mg of emtricitabine and 300mg of tenofovir. It is also available under the brand name Sopat o Truvada and can be stored at 25°C. Each container is to be kept tightly closed, and the medication should be dispensed only as film-coated tablets in the original container. A package insert is available for more information on dosage and administration. Patients should be given the attached medication guide every time Truvada is dispensed.*
Principal Display Panel (100 mg/150 mg Tablet Bottle Label)
Truvada Tablets contain 100mg of emtricitabine and 150mg of tenofovir disoproxil fumarate, which is equal to 123mg of tenofovir disoproxil. They are manufactured by Gilead Sciences Inc. in Canada and should be stored at 25°C. The medication guide should be dispensed to the patient with each dispensing of Truvada. Refer to the package insert for dosage and administration information.*
Principal Display Panel (133 mg/200 mg Tablet Bottle Label)
Truvada tablets are a prescription medication used for the treatment of HIV-1 infection in adults. Each tablet contains 133 mg of emtricitabine and 200 mg of tenofovir disoproxil fumarate, which is equivalent to 163 mg of tenofovir disoproxil. It is recommended to store the medication at 25°C and keep the container tightly closed, and dispense only in the original container. The package insert provides dosage and administration information, and Truvada is only available with a prescription. Gilead Sciences, Inc. manufactures Truvada, and it is made in Canada. The patient should be given the attached Medication Guide each time Truvada is dispensed.*
Principal Display Panel (167 mg/250 mg Tablet Bottle Label)
Truvada tablets contain 167mg of emtricitabine and 250mg of tenofovir disoproxil fumarate (equivalent to 204mg of tenofovir disoproxil). They are meant to be stored at 25°C and dispensed only in their original container. Truvada tablets are manufactured by Gilead Sciences, Inc. in Canada, with an NDC number of 61958-0705-1. The attached Medication Guide should be given to the patient with each dispensed Truvada. Consult the package insert for dosage and administration information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.